Programs

HomePrograms ▶ Partner Grants Without LOI Stage
Partner Grants Without LOI Stage

Important Notes

The application "2020 ATS Research Program Grants Without an LOI Stage" can be found on the Foundant Technologies Website.

These grants skipped the letter of intent (LOI) stage and do NOT require an invitation to submit.

Applicants are strongly advised to read the instructions and eligibility criteria before starting an application.

 

Anticipated Timeline

October 1, 2020

Full Application Submission Opens

December 1, 2020

Full Application Deadline due by 11:59 pm Eastern Time

January 2021

Grantee Notification

February 2021

Grant Start Date

 

Current Partner Grant Opportunities without LOIs


4DX Medical Logo

ATS/4DMedical Research Grant in Asthma using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS)

1 grant available
$50,000 for 1 year

Target Audience:
Investigators interested in research in Asthma using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS)

The focus of this research grant is proposals that are conducting research in asthma using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS). Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility:
• Junior investigators (as defined here)  
• Must meet eligibility requirements for all grants found here

Fully funded by 4DMedical. Please visit 4dmedical.com for more information about our partner.


4DX Medical Logo

ATS/4DMedical Research Grant in COPD using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS)

1 grant available
$50,000 for 1 year

Target Audience:
Investigators interested in research in COPD using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS)

The focus of this research grant is proposals that are conducting research in COPD using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS). Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here) 
• Must meet eligibility requirements for all grants found here

Fully funded by 4DMedical. Please visit 4dmedical.com for more information about our partner.

 

4DX Medical Logo

ATS/4DMedical Research Grant in IPF using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS)

1 grant available
$50,000 for 1 year

Target Audience:
Investigators interested in research in IPF using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS)

The focus of this research grant is proposals that are conducting research in IPF using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS). Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here 

Fully funded by 4DMedical. Please visit 4dmedical.com for more information about our partner.

copd-logos_copdf-logo-one-line.png
ATS/COPD Foundation Research Grant
1 grant available
$40,000 per year for 2 years 

Target Audience:
Investigators interested in research that is relevant to non-CF Bronchiectasis

The focus of this research grant is proposals that have a high likelihood to advance the understanding of the pathophysiology of non-CF Bronchiectasis. Applicants may request up to $40,000 per year for two years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here) 
• Must meet eligibility requirements for all grants found here 

Co-funded by the ATS and the COPD Foundation. Please visit copdfoundation.org or bronchiectasisandntminitiative.org for more information about our partner.

 CSL Behring Logo

ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome (ARDS)

1 grant available
$50,000 per year for 1 year

Target Audience:
Investigators interested in research on ARDS

The focus of this research grant is proposals that advance understanding of acute respiratory distress syndrome (ARDS). Applicants may request up to $50,000 for 1 year. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here) 
• Must meet eligibility requirements for all grants found here 

Fully funded by CSL Behring. Please visit cslbehring.com for more information about our partner.

HPSN
ATS/Hermansky-Pudlak Syndrome Network Research Grant

1 grant available
$40,000 per year for 2 years

Target Audience:
Investigators (junior or established) interested in research focusing on Hermansky-Pudlak syndrome (HPS) pulmonary fibrosis

The focus of this research grant is to accelerate the discovery of innovative treatment strategies for Hermansky-Pudlak syndrome pulmonary fibrosis. Priority will be given to projects that seek to identify novel therapeutic targets or to develop ground-breaking anti-fibrotic drugs against putative molecular targets.

Applicants may request up to $40,000 per year for two years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here) or established investigators at any stage in their career
• Must meet eligibility requirements for all grants found here 
Co-funded by the ATS Research Program and Hermansky-Pudlak Syndrome Network. Please visit hpsnetwork.org for more information about our partner. 


Mallinckrodt Logo
   

ATS/Mallinckrodt Research Grant on COVID-19 in Underrepresented Minorities

1 grant available
$50,000 per year for 1 year

Target Audience:
Investigators interested in research on COVID-19 in underrepresented minority (URM) patient populations

The focus of this research grant is research that contributes to the understanding of COVID-19 that disproportionately affects underrepresented minority (URM) patient groups. URM patient groups includes patients from lower-middle and low-income countries as defined by the World Bank, or the following North American populations: African Americans, Mexican-Americans, Native Americans (American Indians, Alaska Natives, and native Hawaiians), Pacific Islanders, and mainland Puerto Ricans. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here) 
• Must meet eligibility requirements for all grants found here 

Fully funded by Mallinckrodt Pharmaceuticals. Please visit mallinckrodt.com for more information about our partner.


Mallinckrodt Logo

ATS/Mallinckrodt Research Grant in Sarcoidosis

1 grant available
$50,000 for 1 year

Target Audience:
Investigators interested in research that is relevant to sarcoidosis

The focus of this research grant is proposals that advance understanding of sarcoidosis.  
Applicants may request up to $50,000 for 1 year. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here) 
• Must meet eligibility requirements for all grants found here

Fully funded by Mallinckrodt Pharmaceuticals. Please visit mallinckrodt.com for more information about our partner.


Review Process

Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

The ATS Scientific Advisory Committee (SAC) will review the applications. The membership of the SAC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.


ATS Policy on Additional Grant Funding

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SAC will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the ATS Foundation research grant and the other grant. Budgetary overlap is not allowed.


If your question is not answered in the FAQ, contact the Research Program at researchprogram@thoracic.org.

 

 

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Twitter Facebook LinkedIn Instagram YouTube Social Media Page

AMERICAN THORACIC SOCIETY
25 Broadway
New York, NY 10004
United States of America

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: atsinfo@thoracic.org

© 1998 - American Thoracic Society, all rights reserved.